Fundraising Fox

Fortis Therapeutics

5 known investors

fortistx.com ↗

Fortis Therapeutics develops precision cancer therapies that target CD46 proteins on tumor cells while sparing healthy tissue. The company operates in the oncology and biotech field.

BiotechHealthtech

Investors · 5

Avalon BioVenturesSan Diego
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Vivo CapitalPalo Alto · $10M – $50M
Lilly Asia VenturesreportedHong Kong
Osage University PartnersreportedBala Cynwyd

In the news

Fortis Therapeutics Closes $40 Million Series A Financing to Advance Novel Anti-CD46 Therapeutic to Treat Late-Stage Prostate Cancer and Multiple Myeloma - Fortis Therapeuticsfortistx.com · Mar 2021Fortis Therapeutics Raises $40M in Series A Funding - FinSMEsfinsmes.com · Mar 2021News - Fortis Therapeuticsfortistx.com · Mar 2021Fortis Therapeutics Closes $18 Million Series A Financingfortistx.com · Nov 2018Fortis Therapeutics raises $18M to develop cancer treatments – San Diego Union-Tribunesandiegouniontribune.com · Sep 2016Fortis Therapeutics Closes $18 Million Series A Financing to Advance New Antibody Drug Conjugate Therapies for the Treatment of Late-Stage Cancersprnewswire.com · Sep 2016

Frequently asked questions

What does Fortis Therapeutics do?
Fortis Therapeutics develops precision cancer therapies that target CD46 proteins on tumor cells while sparing healthy tissue. The company operates in the oncology and biotech field.
Who are Fortis Therapeutics's investors?
Fortis Therapeutics's investors include Avalon BioVentures, OUP (Osage University Partners), Vivo Capital, Lilly Asia Ventures, Osage University Partners.